Scientific Program - ESR Annual Meeting 2025

Scientific Program


ESR Vasculitis Day
15:30 – 16:00Behçet’s Disease: Navigating the Many Faces of a Complex DisorderDr. Ibrahim Almaghlouth
16:00 – 16:30SAIDs (Systemic AutoInflammatory Diseases) in Focus: When the Innate Immune System Goes RogueDr. David Saadoun
16:30 – 17:00Giant Cell Arteritis: Evolving Paradigms in Diagnosis and TreatmentDr. Aladdin Mohammad
17:00 – 17:15Q&A
17:15 – 17:30Coffee Break
17:30 – 18:00The Invisible Inflammation: Uncovering CNS Vasculitis & CryoglobulinemiaDr. David Saadoun
18:00 – 18:30MRI in CNS Small Vessel Vasculitis and MimicsDr. Iftikhar Ahmad
18:30 – 19:00ANCA Vasculitis in 2025: Evolving Evidence and Emerging TherapiesDr. Aladdin Mohammad
19:00 – 19:15Q&A
19:15 – 19:45Industry Symposium
END OF DAY

Main Conference Day 1


07:30 – 15:00Registration
08:30 – 09:50Session 1: CAR T & Artificial Intelligence
08:30 – 08:50Keynote Lecture: Adopting New Artificial Intelligence (AI) Trends to Reshape Rheumatology PracticeDr. Thomas Hügle
08:50 – 09:20Making Sense of CAR T in Autoimmune ConditionsDr. Chris Wincup
09:20 – 09:40CAR T in Lupus – UAE ExperienceDr. Tahir Khan
09:40 – 09:50Q&A & Certificates
09:50- 10:10Opening Ceremony
10:10 – 10:40Industry Symposium
10:40 – 10:55Coffee Break
10:55 – 12:25Session 2: What is New . WIN
10:55 – 11:20Everything you Need to Know About GLP-1 Receptor Agonists and SGLT-2 InhibitorsDr. Elamin Abdelgadir
11:20 – 11:45Bridging Gaps in JAKi Use Beyond ArthritisDr. Daniel Furst
11:45 – 11:55Q&A & Certificates
11:55 – 12:25Industry Symposium
12:25 – 13:40Lunch
13:40 – 15:10Session 3: Systemic Lupus Erythematosus (SLE) / Antiphospholipid Syndrome (APS)
13:40 – 14:00Lupus Nephris Under the Lens: What’s New? What’s Next?Dr. Oseme Etome
14:00 – 14:20Pitfalls of the 2023 ACR/EULAR Antiphospholipid Syndrome (APS) Classification CriteriaProf. Munther Khamashta
14:20 – 15:00Decoding Systemic Lupus Erythematosus (SLE) / Antiphospholipid Syndrome (APS) in PregnancyDr. Oseme Etome
15:00 – 15:10Q&A & Certificates
15:10 – 16:10Session 4: Rheumatoid Arthritis (RA)
15:10 – 15:35Cracking the Code of Difficult-to-Treat RADr. Daniel Furst
15:35 – 16:00Infection in Rheumatic Conditions: Use of immunomodulators in HIV infectionDr. Aqeel Salem
16:00 – 16:10Q&A & Certificates
16:10 – 16:40Industry Symposium
16:40 – 16:55Coffee Break
16:55 – 18:00Session 5: Neoplasia and Rheumatology
16:55 – 17:20Check it Out! What is New in Check Point Inhibitors in RheumatologyDr. Chris Wincup
17:20 – 17:50
  • 2024 EULAR Points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer
  • DMARDs and Malignancy. Cancer Screening, EULAR Guidance and Beyond
Dr. Ahmed Zayat
17:50 – 18:00Q&A & Certificates
16:10 – 16:40Industry Symposium

END OF DAY 3

07:30 – 15:00Registration
09:50 – 10:00Welcome Remarks
10:00 – 11:45Pediatric Session 1
10:00 – 10:35Monogenic Lupus: Insights into Clinical and Genetic ComplexityDr. Sulaiman Almayouf
10:35 – 11:10Approach to variant of unknown significance interpretation in SLEDr. Adnan AlAli
11:10 – 11:45Atypical Presentations of Juvenile SLEDr. Reem Abdawani
11:45 – 12:00Coffee Break
12:00 – 13:45Pediatric Session 2
12:00 – 12:35Vasculitis in Children: Diagnosis, Management, and Long-Term OutcomesDr. Buthaina Al Athba
12:35 – 13:10Optimizing the Transition from Pediatric to Adult Care: An Expert OpinionDr. Elsadeg Sharif
13:10 – 13:45Targeting the JAK–STAT Pathway in Monogenic Interferonopathies: Clinical Advances and ChallengesDr. Shima Kamal
12:25 – 13:40Lunch

END OF DAY

Main Conference Day 2


07:30 – 15:00Registration
08:30 – 10:00Session 6: How to Treat. HOT
08:30 – 08:55Osteoporosis in Males and Young AdultsDr. Asma Aljaberi
08:55 – 09:20Sequential Therapy in OsteoporosisDr. Mustafa Al Izzi
09:20 – 09:45Sjögren’s – Sicca Symptoms to Sjögren’sDr. Thomas Hügle
09:45 – 09:55Q&A & Certificates
09:55 – 10:25Industry Symposium
10:25 – 10:45Coffee Break
10:45 – 11:45Session 7: How to Treat. HOT
10:45 – 11:10EULAR /PReS recommendation for the management of Still’s diseaseDr. Fatemah Baron
11:10 – 11:35Connective Tissue Disease-associated Interstitial Lung Disease (CTD-ILD) 
11:35 – 11:45Q&A & Certificates
11:45 – 12:15Industry Symposium
12:15 – 13:20Lunch
13:20 – 14:35Session 8: Metabolic Diseases
13:40 – 14:00Asymptomatic Hyperuricemia – To Treat or Not to Treat. A DebateDr. Francis Kynaston-Pearson
Dr. Elhadi Eltayeb Abbas
14:00 – 14:25DMARDs Induced Hepatic Stress: Navigating fatty liver disease and Hepatitis B,C infectionDr. Saeed AlMarzooqi
14:25 – 14:35Q&A & Certificates
14:35 – 14:50Coffee Break
14:50 – 15:50Session 9: Spondyloarthritis (SpA)
14:50 – 15:15Through the Eye of Inflammation: Uveitis in Rheumatology PracticeDr. Aniruddha Agarwal
15:15 – 15:40The Art and Science of Rheumatology: Bridging Evidence and Experience in D2T SpADr. Asal Adnan
15:40 – 15:50Q&A & Certificates
15:40 – 15:50CLOSING

*Disclaimer: Preliminary Agenda as of 29 September 2025, subject to potential modifications without prior notification.

REGISTER NOW